Form D · Venture Capital Fund

OrbiMed Asia Partners II, LP

New York, NY · CIK 0001584561

Offering snapshot reported Aug 15, 2013 · SEC filing

Reported sold
Yet to sell
Offering amount: $300M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 15, 2013InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0
Form D file number
021-201444

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Merrill Lynch, Pierce, Fenner & Smith Incorporated7691

Source: Form D, filed Aug 15, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED ASIA PARTNERS II, L.P.

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value
$108M
Beneficial owners
415
ADV minimum commitment
$10M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES, INC. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP NEW YORK, New York, United States
Custodian AFRASIA BANK LIMITED PORT LOUIS, Mauritius Related to adviser: No
Custodian CHINA INTERNATIONAL CAPITAL CORPORATION BEIJING, China Related to adviser: No
Custodian CITIBANK (INDIA), N.A. MUMBAI, India Related to adviser: No
Custodian CITIGROUP GLOBAL MARKETS INC. NEW YORK, New York, United States Related to adviser: No
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Custodian SHANGHAI PUDONG DEVELOPMENT BANK SHANGHAI, China Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

CITIGROUP GLOBAL MARKETS INC.
SEC 8-8177

JPMORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE9

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-4969310917

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Carl L. Gordon Director
W. Carter Neild Director
N/A Orbi Med Advisors Ii Limited Executive
N/A Orbi Med Asia Gp Ii, L.P. Executive
Jonathan T. Silverstein Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Orbi Med Advisors Llc 601 Lexington Avenue, 54 Th Floor
New York, NY, 10022